Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 2,091,100 | 2,028,500 | 1,894,500 | 1,757,900 | 1,832,600 |
| Cost of Goods | 1,765,100 | 1,693,400 | 1,555,200 | 1,430,700 | 1,532,400 |
| Gross Profit | 326,000 | 335,100 | 339,300 | 327,200 | 300,200 |
| Operating Expenses | 287,700 | 281,700 | 309,100 | 272,100 | 251,800 |
| Operating Income | 38,400 | 53,800 | 30,400 | 55,800 | 48,800 |
| Interest Expense | 9,500 | 6,600 | 9,900 | 10,600 | 10,000 |
| Other Income | 0 | 0 | -4,300 | 0 | 0 |
| Pre-tax Income | 28,900 | 47,200 | 16,200 | 45,200 | 38,800 |
| Income Tax | 7,300 | 12,100 | 9,400 | 26,300 | 15,900 |
| Net Income Continuous | 21,600 | 35,100 | 6,800 | 18,900 | 22,900 |
| Net Income | $21,600 | $35,100 | $6,800 | $18,900 | $22,900 |
| EPS Basic Total Ops | 0.70 | 1.16 | 0.23 | 0.64 | 0.78 |
| EPS Basic Continuous Ops | 0.70 | 1.16 | 0.23 | 0.64 | 0.78 |
| EPS Diluted Total Ops | 0.69 | 1.14 | 0.22 | 0.63 | 0.77 |
| EPS Diluted Continuous Ops | 0.69 | 1.14 | 0.22 | 0.63 | 0.77 |
| EPS Diluted Before Non-Recurring Items | 1.94 | 1.53 | 1.50 | 1.65 | 1.27 |
| EBITDA(a) | $96,500 | $106,100 | $72,700 | $92,800 | $80,700 |